[Treatment of peptic ulcer with histamine H2 receptor antagonists]
- PMID: 19347
[Treatment of peptic ulcer with histamine H2 receptor antagonists]
Abstract
Histamine H2-receptor antagonists (Burimamide, Metiamide and Cimetidine as the most recent generation) may drastically inhibit gastric acid secretion stimulated by histamine, pentagastrin, insulin, 2-deoxyglucose or an intragastrically instilled meal, respectively. This inhibitory action may explain the beneficial effects of H2-antagonists in the treatment of active peptic ulceration. On Cimetidine administered at a usual dosage over a 4--6 week period, serious side-effects must not be expected. At present studies aim to establish a Cimetidine dosage which, on long-term treatment, may reduce ulcer recurrency.
Similar articles
-
H2 receptor antagonists.Am J Hosp Pharm. 1978 Feb;35(2):141-5. Am J Hosp Pharm. 1978. PMID: 24338 Review.
-
Histamine H2-receptor antagonists and gastric acid secretion -- a progress report.Klin Wochenschr. 1976 Oct 1;54(19):911-4. doi: 10.1007/BF01469004. Klin Wochenschr. 1976. PMID: 10467
-
[Current antihistaminic preparations in treatment of peptic ulcer (review of foreign literature)].Klin Med (Mosk). 1978 Jun;56(6):17-24. Klin Med (Mosk). 1978. PMID: 27666 Review. Russian. No abstract available.
-
[Treatment of peptic ulcer in the Zollinger-Ellison syndrome with histamine H2-receptor antagonists (author's transl)].Dtsch Med Wochenschr. 1977 Nov 25;102(47):1709-12. doi: 10.1055/s-0028-1105561. Dtsch Med Wochenschr. 1977. PMID: 21785 German.
-
[Cimetidine; new hope for ulcer patients?].Ned Tijdschr Geneeskd. 1978 Jun 17;122(24):866-70. Ned Tijdschr Geneeskd. 1978. PMID: 351434 Review. Dutch. No abstract available.